Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) is an endoplasmic reticulum (ER) protein that can be secreted and protect dopamine neurons and cardiomyocytes from ER stress and apoptosis. The mechanism of action of extracellular MANF has long been elusive. From a genetic screen for mutants with abnormal ER stress response, we identified the gene Y54G2A.23 as the evolutionarily conserved C. elegans MANF orthologue. We find that MANF binds to the lipid sulfatide, also known as 3-O-sulfogalactosylceramide present in serum and outer-cell membrane leaflets, directly in isolated forms and in reconstituted lipid micelles. Sulfatide binding promotes cellular MANF uptake and cytoprotection from hypoxia-induced cell death. Heightened ER stress responses of MANF-null C. elegans mutants and mammalian cells are alleviated by human MANF in a sulfatide-dependent manner. Our results demonstrate conserved roles of MANF in sulfatide binding and ER stress response, supporting sulfatide as a long-sought lipid mediator of MANF's cytoprotection. up-regulation or transgenic MANF overexpression has been shown to protect dopaminergic neurons, cerebral neurons, Purkinje cells, retinal neurons, pancreatic β cells and cardiomyocytes from degeneration or cell death 7,8,13,19-22 . Despite potent cytoprotective effects and emerging therapeutic potentials of MANF for neurodegenerative, cardiovascular, diabetic and ischemic disorders, how extracellular MANF signals to cells and confers cytoprotection has remained largely elusive. No MANF receptor has been identified despite over a decade of research since its cytoprotective activity was discovered in 2003. Although it has been suggested that MANF might bind to certain cell surface lipids via its N-terminal Saposin-like domain, the molecular identity of MANF-binding lipids and how its potential lipid-binding ability might contribute to cytoprotection are unknown. Understanding the mechanisms of action of extracellular MANF in cytoprotection thus remains a key challenge of the field.
Introduction
Oxidizing environment is essential for protein folding and functions in the ER of eukaryotic cells [1] [2] [3] . The Ero1-PDI enzymatic cascade in the ER mediates the oxygendependent disulfide bond formation and proper folding of transmembrane or secreted proteins. Severe hypoxia (reduced ambient oxygen), as frequently occurs in ischemic and neoplastic disorders, causes cellular ER stress response independently of the wellcharacterized Hypoxia Inducible Factor (HIF) pathway [4] [5] [6] . Eukaryotic cells actively maintain protein folding and redox homeostasis in the ER upon hypoxic and oxidative stresses by regulating numerous cellular factors to promote normal physiological functions and cytoprotection. Among such factors that have been studied, MANF is an enigmatic family of proteins with rather unique mode and mechanisms of action.
Mammalian MANF was initially identified for its neurotrophic effects on dopaminergic neurons 7 . It is a 20 kD small secreted protein that exhibits no amino acid sequence similarities to any other classical families of target-derived neurotrophic factors, including GDNF, NT3 and BDNF. MANF family proteins are highly evolutionarily conserved with both human and Drosophila orthologues being capable of promoting dopamine neuron survival [8] [9] [10] . Its N-terminus contains a structural fold similar to Saposin proteins while its C-terminus contains a SAP (SAF-A/B, Acinus, and PIAS) domain similar to that of Ku70, an inhibitor of proapoptotic Bax 11, 12 . MANF is widely expressed in the body, with levels particularly high in the nervous system, kidney, heart and pancreatic β cells [13] [14] [15] . Cellular MANF abundance and secretion are strongly upregulated by ER stress-related stimuli, including hypoxia, ischemia, chemical treatments with tunicamycin or tharpsigargin 13, [15] [16] [17] . Because of its secretion from cardiomyocyte and autocrine/paracrine effects on cardiovascular functions, MANF has been termed "cardiomyokine" playing critical roles in cardioprotection, hypertrophy and heart failure 18 .
MANF KO mice are diabetic with abnormal activation of unfolded protein response in pancreatic islets, while its gain-of-function by exogenous MANF addition, physiological
A genetic screen identifies a C. elegans manf-1 mutant
We sought to identify new regulators of HIF-independent ER stress response by performing forward genetic screens for C. elegans mutants with abnormal ER stress responses. The C. elegans gene hsp-4 encodes the orthologue of human ER chaperone BiP and is a well-established ER stress-inducible gene [25] [26] [27] [28] . By random mutagenesis of the C. elegans transgenic strain in which GFP reporter expression is driven by the hsp-4 promoter, we isolated mutants with constitutive GFP expression even without externally induced ER or hypoxic stresses. One mutation dma1 caused fully recessive, completely penetrant and strong constitutive activation of hsp-4p::GFP, predominantly in the intestine of C. elegans (Fig. 1a ). We genetically mapped the mutation dma1 by single nucleotide polymorphism-based linkage analysis and molecularly identified the causal gene ( Supplementary Fig. 1 ). Based on RNA interference (RNAi) phenocopy of the dma1 mutant and its transformation rescue with transgenic arrays of wide-type alleles, we determined that dma1 defines a previously uncharacterized gene Y54G2A.23, which encodes the sole orthologue of the highly evolutionarily conserved MANF protein family (Fig. 1b, c and Supplementary Fig. 1 ).
CRISPR-mediated deletions of Y54G2A.23 caused constitutively high levels of hsp-4p::GFP with phenotype identical to that of dma1 (Fig. 1c ). We found that hsp-4p::GFP expression by dma1 was suppressed by RNAi against xbp-1 or ire-1, which encodes an ER stress sensor and activator of the ER stress-responding transcription factor XBP-1 (Fig. 1c ). The mutation dma1 as confirmed by Sanger sequencing is a missense transition mutation that converts serine 75 to leucine at the N-terminus of MANF-1 (named for Y54G2A.23; Fig. 1b and Supplementary Fig. 1d and 2 ). 6 C. elegans manf-1 is widely expressed in several major tissues including intestine, hypoderm, spermatheca and nervous systems, based on an integrated transcriptional reporter in which GFP is driven by the endogenous manf-1 promoter (Fig.   1d ). The constitutive expression of hsp-4p::GFP in intestinal cells of dma1 mutants was fully rescued by expression of manf-1(+) driven by the intestine-specific ges-1 promoter, the ubiquitously active rpl-28 promoter or a transgenic array expressing human MANF driven by the C. elegans manf-1 promoter ( Fig. 1e and 1f ). By contrast, a mutant manf-1(C146G) carrying the substitution of an invariant cysteine C146 completely conserved in the MANF protein family failed to rescue the constitutive hsp-4p::GFP expression of dma1 mutants (Fig. 1e ). In addition, we found that chronic (24 hrs) but not acute (1 hr) exposure of manf-1 mutants to tunicamycin, an ER stress-inducing protein glycosylation inhibitor, decreased progeny numbers to a larger degree in manf-1 mutants than wild type (Supplemental Fig. 1e ). These findings indicate that C. elegans manf-1 plays an evolutionarily conserved role in regulating ER stress responses.
Both C. elegans and human MANFs bind directly to sulfatide
To explore novel mechanisms of MANF's cytoprotection, we first examined structural motifs of the hitherto uncharacterized C. elegans MANF-1 (Ce-MANF). Based on homology-based structural modelling against the crystal structure of Hs-MANF 29 , Ce-MANF contains a saposin-like fold at the N-terminus and a SAP-like C-terminal domain ( Supplementary Fig. 2a, b ). Since Saposin family proteins solubilize various sphingolipids for degradation in lysosomes 30 , we tested the binding of purified Ce-MANF to an array of 16 structurally defined sphingolipids spotted on a nitrocellulose membrane (Echelon sphingostrip lipid overlay assay). We found that Ce-MANF binds specifically to one single lipid species, corresponding to sulfatide ( Fig. 2a ). Purified Hs-MANF also exhibited binding to sulfatide, prepared from either bovine brains or synthetic sources ( Fig. 2b, Supplementary Fig. 2e ). Using lipid overlay assays, we examined other lipids that are structurally similar to sulfatide but otherwise lacking or with variant chemical groups and found that both the acyl chain and sulfate are essential for the binding (Fig.   2c ). To determine whether MANF can bind to sulfatide freely in solution we performed size exclusion chromatography of micelle-reconstituted (by Tween 20 and dodecyl maltoside detergents) Hs-MANF with or without sulfatide. We observed association of Hs-MANF with detergent micelles only when sulfatide was present ( Fig. 2d, e ). In addition, sulfatide specifically deterred enzymatic digestion of Hs-MANF by trypsin ( Fig.   2f , Supplementary Fig. 3a , b) and protected Hs-MANF against thermal denaturation ( Supplementary Fig. 3c ). These results identify sulfatide as a sulfated glycolipid that directly binds to Ce-MANF and Hs-MANF.
Sulfatide binding mediates conserved cytoprotection of MANF
Since MANF protein family members are highly evolutionarily conserved ( Supplementary Fig. 2c , f), we investigated whether MANF binding by sulfatide might facilitate cytoprotection of MANF in both C. elegans and mammalian cells.
In C. elegans, we found that the constitutively high expression level of hsp-4::GFP in manf-1 mutants can be fully rescued by transgenic arrays expressing either wild-type C. elegans manf-1 or human MANF (Fig. 1c , e, f). We generated HEK293T lentiviral stable cell lines that constitutively express and secrete Hs-MANF, which carry a C-terminal V5 epitope for tagging and to minimize ER retention 31 . Using the secreted Hs-MANF collected from cell culture media, we found that manf-1 null C. elegans mutants can be partly rescued by incubation with exogenous Hs-MANF protein in the presence of sulfatide in liquid culture ( Fig. 3a-c) . The reduction of hsp-4::GFP levels was accompanied with increased levels of Hs-MANF uptake in C. elegans manf-1 null mutants (Fig. 3c ). The uptake of Hs-MANF in C. elegans was mediated, at least in part, by specific dynamin-dependent endocytosis machinery ( Fig. 3d ) in C. elegans and was independent of epitope tagging, bacterial food presence or stages of animals but dependent on presence of sulfatide ( Supplementary Fig. 3d and 5c). The uptaken Hs-MANF appeared widely localized in C. elegans tissues ( Fig. 3e ). These results indicate that Hs-MANF can by uptaken in a sulfatide-dependent manner and rescue the ER stress response of manf-1 null mutants in C. elegans.
We next examined effects of MANF and sulfatide in cultured mammalian cells.
MANF::V5 from the conditioned medium of the lentiviral stable line can bind to sulfatide ( Fig. 4a ) and protect both HEK293T cells as well as the H9C2 cardiomyocyte cell line after severe ER stress or hypoxia with glucose deprivation conditions ( Supplementary   Fig. 4a -c). To probe the specific role of sulfatide binding in conferring cytoprotection, we compared the effect of wild-type Hs-MANF with a K112L mutant exhibiting reduced binding activity to sulfatide. We found that sulfatide did not bind to the Hs-MANF paralogue cerebral dopamine neurotrophic factor (CDNF) ( Supplementary Fig. 2e ). The evolutionarily conserved surface lysine residue K112 in Hs-MANF (K88 in crystal structure of Hs-MANF, substituted with leucine in CDNF) partly accounts for the difference between MANF and CDNF 29 . We found that the MANF (K112L) mutant exhibited markedly reduced binding to sulfatide, without affecting expression levels ( Fig.   4a -c). The K112L mutation attenuated the survival-promoting effect of Hs-MANF in both HEK293T and H9C2 cells ( Fig. 4d , e and Supplementary Fig. 4c ). Cytoprotective effects of Hs-MANF was also blocked by the O4 monoclonal antibodies against sulfatide, further demonstrating the essential role of endogenous sulfatide for cytoprotection of Hs-MANF ( Fig. 4d, e ). These results indicate that potent cytoprotective effects of Hs-MANF are facilitated by specific binding to sulfatide.
Binding to sulfatide promotes cellular uptake of MANF
Given the abundance of cell-surface and extracellular sulfatide as well as its known roles in membrane trafficking 23,24 , we hypothesize that sulfatide facilitates MANF functions by promoting cellular uptake of MANF both in C. elegans ( Fig. 3c-e ) and mammalian cells. Indeed, we found that secreted wild-type but not K112L mutant Hs-MANF proteins from conditioned media were efficiently uptaken by target HEK293T cells in a dose-dependent manner ( Fig. 5a, b ). The uptaken Hs-MANF appeared to extensively co-localize with the MANF-interacting protein GRP78 (i.e. the ER resident chaperone BIP), indicating its likely endocytosis following cell surface binding (Fig. 5c ).
The uptake of wild-type Hs-MANF can be further enhanced by exogenous sulfatide or increased endogenous levels of sulfatide in target cells by over-expressing the gene encoding the sulfatide-biosynthetic enzyme cerebroside sulfotransferase (CST) ( Fig. 5a and Supplementary Fig. 5a ). To test whether MANF might be endocytosed to promote the intracellular degradation of sulfatide, as the canonic saposin-B protein does, we measured sulfatide levels in Hs-MANF over-expressing and CRISPR-mediated KO cells and found Hs-MANF does not affect sulfatide levels ( Supplementary Fig. 5b ). As the V5-tagged MANF, the tag-free MANF was similarly uptaken by target cells in a sulfatidedependent manner ( Supplementary Fig. 5c ). These results indicate that MANF binds to sulfatide for efficient cellular endocytosis, not for degradation.
We next characterized the role and mechanism of action of the sulfatidemediated enhancement of Hs-MANF endocytosis. Endogenous sulfatide is biosynthesized in ER and Golgi while MANF is normally retained in the ER and upregulated by ER stress and hypoxia, followed by secretion and cellular release through the ER/Golgi pathway 16, 19 . We verified that severe hypoxia can indeed drastically increase the abundance of Hs-MANF into the extracellular medium while its secretion can be blocked by brefeldin A, a classic inhibitor of the ER/Golgi secretion pathway ( Supplementary Fig. 6a, b ). In addition, we found that the ratio of bound/free MANF increases at pH 6.0 and 6.75 ( Supplementary Fig. 6c ), characteristic of the Golgi lumen.
These results suggest that sulfatide is likely associated with MANF during its secretion and facilitates the subsequent endocytosis of MANF to target cells.
To minimize the contribution from endogenous and other sources of sulfatide present in the cell culture medium that contains serum and thus sulfatide, we collected the secreted Hs-MANF in PBS and found that adding exogenous sulfatide to Hs-MANF in PBS markedly increased Hs-MANF endocytosis in a dose-and time-dependent manner ( Supplementary Fig. 7a -c). Furthermore, treatment with sulfatide antibodies or its degrading enzyme sulfatase in the cell culture medium attenuated Hs-MANF endocytosis ( Supplementary Fig. 7a ). To exclude the potential involvement of other factors in the conditioned medium indirectly affecting endocytosis, we purified Hs-MANF from cell culture media using affinity antibodies against the V5 epitope in Hs-MANF and found that antibodies against sulfatide inhibited endocytosis while exogenous sulfatide drastically enhanced endocytosis ( Supplementary Fig. 7b ). The enhancement of Hs-MANF endocytosis by sulfatide was apparently specific since sulfatide exhibited no enhancing effects on the endocytosis of another two distinct secreted proteins ( Supplementary Fig. 7d ), and can be blocked by inhibitors of endocytic machineries 32 ( Supplementary Fig. 7e ). These results provide further evidence that the sulfatide level is a critical and specific determinant of Hs-MANF endocytosis.
MANF-sulfatide alleviates ER stress response in cultured cells

C. elegans experiments clearly indicated the roles of both Ce-MANF and Hs-
MANF in alleviating ER stresses ( Fig. 1 and Fig. 3 ). To further examine whether MANF can alleviate ER stresses also in mammalian cells, we monitored the formation of G3BP-marked stress granules in U2OS cells 33, 34 evoked by thapsigargin (Tg), an ERstress triggering inhibitor of mammalian sarco/endoplasmic reticulum Ca² + -ATPase. We found that Tg induced a time-dependent stress granule formation that were markedly attenuated by pretreatment with Hs-MANF ( Fig. 6a ). Compared with Hs-MANF, the Hs-MANF K112L mutant exhibited markedly reduced ability to attenuate stress granule formation ( Fig. 6b, c) . The effect of exogenous sulfatide manifested more prominently with lower doses of Hs-MANF, suggesting that endogenous sulfatide bound to Hs-MANF affected stress granule formation ( Fig. 6c ). These results support the notion that sulfatide-bound MANF alleviates ER stress responses also in mammalian cells.
Discussion
The cytoprotective and ER stress-alleviating effects of MANF are highly evolutionarily conserved [8] [9] [10] 13 . In mammals, MANF has been shown to be particularly effective in protecting dopamine neurons, retinal ganglion cells and cardiomyocytes against oxidative and ER stresses 8, 16, 19 . However, molecular mechanisms of how secreted MANF elicits cytoprotection have been undefined. Our studies identify sulfatide as a lipid interactor of MANF and the sulfatide-binding capacity is critical for cytoprotective effects of MANF. We further demonstrate that sulfatide promotes cellular uptake of MANF in both C. elegans and mammalian cells and that C. elegans manf-1 mutants can be rescued by human MANF, suggesting highly evolutionarily conserved mechanisms by which MANF alleviates ER stress and cell toxicity under hypoxic and ER stress conditions. Both Ce-MANF and Hs-MANF contain saposin-like structural folds at N-termini ( Supplementary Fig. 2) 13 . Limited proteolysis by trypsin digestion followed by mass spectrometry identified predominantly the N-terminal part of Hs-MANF protected upon sulfatide addition, suggesting that the N-terminal saposin-like domain of MANF binds to sulfatide directly ( Supplementary Fig. 3a, b ). Hypoxia, which lowers pH of the extracellular environment, promotes MANF secretion ( Supplementary Fig. 6b ) and likely enhances cytoprotection against hypoxic toxicity. Several other saposin-like proteins have been shown to bind to sphingolipids; in particular, saposin-B binds to and presents sulfatide to arylsulfatase A for sulfatide degradation in the lysosome 30 . Unlike saposin-B, however, MANF does not affect sulfatide levels ( Supplementary Fig. 5b ). Our findings suggest that MANF retains the sulfatide-binding capacity by the conserved saposin-like structural fold and is molecularly chaperoned by sulfatide, rather than presenting sulfatide for degradation, through the secretion pathway and extracellular milieu to facilitate eventual cellular uptake and cytoprotection in target cells.
Sulfatide-dependent cellular uptake of MANF also suggests a previously unappreciated mechanism of its neurotrophic activity. Based on collective evidence from C. elegans genetics, in vitro lipid-protein biochemistry and mammalian cell culture model, we propose that extracellular sulfatide-bound MANF enters the cell through Sulfatide is biosynthesized first in the ER where the ceramide moiety is converted to galactocerebroside and subsequently sulfated to generate sulfatide by CST in the Golgi. Arylsulfatase A (ARSA) is activated by saposin B and degrades sulfatide in the lysosome. Intriguingly, the C. elegans genome appears to encode a homolog (sul-2) of ARSA but not CST. We speculate that C. elegans might take sulfatide from its feeding bacteria to facilitate MANF signaling, although it remains also possible that C. elegans MANF relies on endogenous sulfatide-like lipids for trafficking and paracrine effects across tissues. In the mammalian nervous system, sulfatide is present primarily on the extracellular leaflet of the oligodendroglia-derived plasma membrane. However, sulfatide is also present in extracellular matrix, blood serum and on the extracellular membrane leaflet of many other cell types. Thus, it is conceivable that sulfatide as a lipid chaperone facilitates MANF travelling across cells and also as a cell-surface lipid-type receptor mediates the paracrine cytoprotection of MANF in vivo.
Aberrant levels and metabolism of sulfatide cause metachromatic leukodystrophy characterized by severe neuropathy and are associated with Parkinson's disease, Alzheimer's disease, cardiovascular disorders and cancer 24, 35 . The discovered physical interaction between MANF and sulfatide as well as the functional importance of their interaction for cytoprotection should help understand their respective roles in physiology and therapeutic potentials in many pathophysiological settings.
METHODS
C. elegans strains and assays
C. elegans strains were cultured with standard procedures unless otherwise specified.
The N2 Bristol strain was used as the reference wild-type strain, and the polymorphic Hawaiian strain CB4856 was used for genetic mapping and SNP analysis 36, 37 . Forward genetic screen for constitutive GFP reporter-activating mutants after ethyl methanesulfonate (EMS)-induced random mutagenesis was performed as described previously 38, 39 . To generate manf-1 null alleles in C. elegans, we used CRISPR-Cas9 to induce double stranded breaks and subsequent non-homologous end joining event caused various deletions of the manf-1 gene and constitutive activation of hsp-4p::GFP.
Feeding RNAi starting from larval L1 stages was performed as previously described 40 .
Transgenic strains were generated by germline transformation as described 41 .
Transgenic constructs were co-injected (at 10 -50 ng/μl) with unc-54p::mCherry, and lines of mCherry+ animals were established. Strains used are as follows: zcIs4, manf- MANF knock out HEK293T cells were generated using the CRISPR-Cas9 system as previously described 43 . Briefly, the online design tool (http://crispr.mit.edu/) was used to select two high-score guide RNA(gRNA) target sites located at first and the last exons containing a 20-base pair (bp) target sequence (targeting sequences were GCGGTTCAGTCGGTCGGCGG and GTGCACGGACCGATTTGTAG). Two pairs of 24or 25-mer oligos for each guide were designed with BbsI restriction enzyme cutting site.
The oligos were annealed and phosphorylated, then cloned into pSpCas9 (BB) plasmid (pX330) (Addgene plasmid ID 42230). HEK293T cells were transiently transfected with two CRISPR/Cas9 construct targeting MANF and puromycin expression construct. The next day, cells were selected with puromycin for 2 days and subcloned to form single colonies. MANF KO clones were identified by PCR screen. The obtained clones are validated by qPCR and immunoblot using an antibody against MANF.
DNA constructs and Lentiviral Transfection
The pLX304-MANF and GAL3ST1 (also known as CST) plasmids were purchased from DNASU (Tempe, AZ, USA) and the pLX304-MANF (K112L) was generated using Q5 site-directed mutagenesis (New England Biolabs, Beverly, MA, USA). The tag free pLX304-MANF was generated using Q5 site-directed mutagenesis to remove the sequence encoding V5 tag. C. elegans constructs for transgenic strains were generated by direct PCR and PCR fusions (plasmids and primers available upon request).
For lentiviral transfection, the plasmids with packaging plasmids were cotransfected into HEK293FT (with a ratio of 2:1.5:1.5) using Turbofect reagent (Thermo 
Compound treatment
The compounds used in this study were as follows: pilipin III (C 35 
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